Clinical trials
Phase 2/3 Head and Neck Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bicara Therapeutics | 1 |
| BioNTech SE | 1 |
| Dana-Farber Cancer Institute | 1 |
| Inhibrx Biosciences, Inc | 1 |
| M.D. Anderson Cancer Center | 1 |
| Monopar Therapeutics | 1 |
| Nektar Therapeutics | 1 |
| Radiation Therapy Oncology Group | 1 |
| Sanofi | 1 |
| University of California, Irvine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 12 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Oropharyngeal Neoplasms | 3 |
| Hypopharyngeal Neoplasms | 2 |
| Laryngeal Neoplasms | 2 |
| Mouth Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Breast Neoplasms | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.